Pleomorphic xanthoastrocytoma (PXA) is a rare tumor with good prognosis after surgery. Few cases of anaplastic PXA (either de novo or secondary to transformation of a recurrent low grade PXA) have been reported. Moreover, primary anaplastic PXA with dissemination at diagnosis has been described only in two patients, to our knowledge. We report the first case of primary multicentric anaplastic PXA and discuss its atypical features and the pertinent literature.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jocn.2012.09.046 | DOI Listing |
Ann Med Surg (Lond)
October 2024
Department of Neurosurgery, UHC Habib Bourguiba.
Neurohospitalist
October 2024
Radiation Oncology Unit, REM Radioterapia Srl, Viagrande, Italy.
J Neuropathol Exp Neurol
May 2024
Department of Laboratory Medicine and Pathology, Mayo Clinic Rochester, Minnesota, USA.
Purpose: Although fewer than 5% of high-grade gliomas (HGG) are BRAF-V600E mutated, these tumors are notable as BRAF-targeted therapy shows efficacy for some populations. The purpose of this study was to evaluate response to the combination of encorafenib with binimetinib in adults with recurrent BRAF-V600-mutated HGG.
Patients And Methods: In this phase 2, open-label, Adult Brain Tumor Consortium (ABTC) trial (NCT03973918), encorafenib and binimetinib were administered at their FDA-approved doses continuously in 28-day cycles.
Cureus
January 2024
Radiology, Tokyo Medical and Dental University, Tokyo, JPN.
We present a unique case of a 45-year-old male with cerebral palsy, who experienced walking difficulties and altered consciousness. The initial MRI revealed an intraventricular mass that rapidly enlarged over a month, consisting of two distinct components with different characteristics on CT and MRI, and was associated with agenesis of the corpus callosum. Despite initial treatment, surgical intervention was necessary, where preoperative imaging suggested an exophytically growing glioblastoma.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!